Scotiabank has recently initiated Tempest Therapeutics Inc (TPST) stock to Sector Outperform rating, as announced on March 14, 2024, according to Finviz. Analyst ratings are significant because they ...

Pre-earnings options volume in Tempest Therpeutics is normal with calls leading puts 22:1. Implied volatility suggests the market is ...

The company’s shares closed yesterday at $87.12. Farmer covers the Healthcare sector, focusing on stocks such as Inmune Bio, BioMarin Pharmaceutical, and Tempest Therapeutics. According to TipRanks, ...

On Monday, Tempest Therapeutics Inc (TPST) stock saw a modest uptick, ending the day at $0.94 which represents a slight increase of $0.03 or 3.30% from the prior close of $0.91. The stock opened at $0 ...

The stock of Tempest Therapeutics Inc (TPST) has gone down by -14.45% for the week, with a -33.73% drop in the past month and a -38.49% drop in the past quarter. The volatility ratio for the week is ...

At close: November 5 at 4:00 PM EST ...

A global research collaboration, including scientists from the University of Liverpool, has provided new insights into superheavy elements by exami ...

Dyne Therapeutics Inc.-2.70% $2.94B ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.